This means that if your healthcare provider prescribes the combination of semaglutide and phentermine, you may need to check your blood sugar levels more frequently and adjust your diabetes medications more often
Health Risks Linked to Ozempic Ozempic, generically known as Semaglutide, is a GLP-1 receptor agonist that mimics the incretin hormone to manage blood sugar, slow gastric emptying, and promote satiety
Compared with those who didn't take GLP-1s, those who did had a reduction of 10% to 20% in heart failure, cardiac arrest, lung failure, and pneumonia, and Alzheimer's disease and other types of dementia
These letters contributed to the significant uptick an increase of 50% overall in the number of CDER warning letters issued in FY 2025
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
Wilding JPH, Batterham RL, Calanna S et al